Clin2
NCT07428213Possibly a fitNot yet recruiting

PSMA PET imaging for recurrent meningioma

Meningioma

Part of Brain & nervous system, Cancer clinical trials.

This study uses a special PET scan to see if a protein called PSMA is present on recurrent meningiomas. The results will help plan a future treatment that targets this protein with radioactive medicine.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You have been diagnosed with a type of brain tumor called meningioma that has come back after prior treatment such as surgery, radiation, or other therapies.
  • You are at least 18 years old.
  • You are able to undergo a PET scan using the radioactive tracer [18F]PSMA, without having any allergies to its ingredients.
  • You have not received antiangiogenic therapy (a treatment that stops blood vessel growth) within the last 60 days.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06830356Recruiting
PET-guided radiation for high-risk meningiomas

This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.

Aviano, Pordenone
NCT06937268Not yet recruiting
PET scan for meningioma radiation planning

This trial uses a special PET scan (DOTATATE) to help plan radiation treatment for meningioma, a type of brain tumor. It aims to make radiation more precise, possibly reducing side effects.

Vancouver, British Columbia
NCT05022914Recruiting
PSMA PET/CT scan for PSA relapse after prostate surgery

This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.

Florence
NCT05263466Not yet recruiting
Testing a radioactive PSMA scan for brain tumor surgery planning

This study tests whether a special radioactive scan that targets PSMA can help identify a high-grade brain tumor in people who are about to have surgery. It may help doctors better target treatment by confirming the tumor’s PSMA features using a radiolabeled imaging approach.

London
NCT06657131Recruiting
PSMA PET scan for prostate cancer recurrence

This trial looks at how well a special PET scan (called PSMA PET) can find prostate cancer that has come back after treatment. It uses a radioactive tracer to spot cancer cells. Your doctor may already have ordered this scan as part of your regular care.

Düsseldorf, North Rhine-Westphalia
NCT06690970Recruiting
PSMA PET/CT scan for people with or suspected to have cancer

This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.

Hefei, Anhui

Hear when a new Meningioma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.